Alfacalcidol
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Alfacalcidol |
| DrugBank ID | DB01436 |
| KG Predictions | 56 |
| DL Predictions (≥0.7) | 39 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 56 knowledge graph predictions and 39 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| hyperparathyroidism | KG |
| hypoparathyroidism | KG |
| renal osteodystrophy | KG |
| osteitis fibrosa | KG |
| hyperparathyroidism | KG |
| hypoparathyroidism | KG |
| renal osteodystrophy | KG |
| osteitis fibrosa | KG |
| hyperparathyroidism | KG |
| hypoparathyroidism | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB01436
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.